NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
Clinical Trials
35 trialsNCT03734653 2025-11-06
Testosterone Therapy in Castration Resistant Prostate Cancer
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT03507608 2025-10-16
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT06520449 2025-09-25
NTA-476
Melbourne Theranostic Innovation Centre
Phase EARLY_PHASE1 Completed
NCT04576871 2025-08-28
Re-treatment 225Ac-J591 for mCRPC
Weill Medical College of Cornell University
Phase EARLY_PHASE1 Completed
NCT04301414 2025-08-07
Neo-Red-P
Columbia University
Phase EARLY_PHASE1 Completed
NCT03987217 2025-05-14
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
University of Utah
Phase EARLY_PHASE1 Completed
NCT03661437 2025-04-11
Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy
City of Hope Medical Center
Phase EARLY_PHASE1 Completed
NCT05110495 2025-02-17
WINGMEN
University of Oxford
Phase EARLY_PHASE1 Completed
NCT06359821 2025-02-14
Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer
Sichuan University
Phase EARLY_PHASE1 Completed
NCT03232164 2024-12-12
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT02952469 2024-09-03
Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC
University of Iowa
Phase EARLY_PHASE1 Completed
NCT04067960 2024-08-14
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02113657 2024-05-24
T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03358563 2024-05-03
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT04726033 2024-05-01
CUPID
Telix Pharmaceuticals (Innovations) Pty Limited
Phase EARLY_PHASE1 Completed
NCT01253213 2023-08-01
BR55 in Prostate Cancer: an Exploratory Clinical Trial
Bracco Diagnostics, Inc
Phase EARLY_PHASE1 Completed
NCT02391025 2023-06-18
Gallium-68 Citrate PET Used in Prostate Cancer
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT04158817 2023-04-18
68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and Restage
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Completed
NCT04282967 2023-04-11
Streaming Web-based Exercise At Home: A Pilot Study
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT04976257 2023-04-07
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT02534376 2023-02-22
Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT02826382 2023-01-12
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Five Eleven Pharma, Inc.
Phase EARLY_PHASE1 Completed
NCT04266392 2022-05-05
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand
Stony Brook University
Phase EARLY_PHASE1 Completed
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT04060043 2021-05-10
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer
CMX Research
Phase EARLY_PHASE1 Completed
NCT04282824 2020-12-02
MSG PSMA PET
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT02357121 2020-09-21
FLA
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT00214422 2019-07-19
Intensity Modulated Radiation Therapy for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT02646319 2019-06-06
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02190279 2019-04-23
18F-DCFBC PET/CT in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT02115828 2018-07-20
A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT02033447 2017-05-10
MAGNABLATE I
University College London Hospitals
Phase EARLY_PHASE1 Completed
NCT01050842 2017-03-23
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02139371 2014-12-12
Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Rigshospitalet, Denmark
Phase EARLY_PHASE1 Completed